<DOC>
	<DOC>NCT01507935</DOC>
	<brief_summary>This study is initiated to investigate the effect of infant formulas with added specific prebiotic oligosaccharides on the reduction of specific potential pathogens and/or toxins.</brief_summary>
	<brief_title>Colonisation Resistance Study</brief_title>
	<detailed_description />
	<criteria>Healthy term infants (gestational age 37 to 42 weeks) aged 22.5 months at inclusion Fully formula fed for at least one week (not applicable for the breastfeeding reference group since these infants must be exclusively breastfed before and throughout the study) Parents' or guardian's written informed consent Being weaned before inclusion (introduction of any other foods other than formula or breast milk.) Moderate or severe acute malnutrition, defined as weightforage and sex below 2 zscores of the median WHO growth standards Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps) Significant congenital abnormality that could affect the study results Use of systemic antibiotics or antimycotic drugs in the 4 weeks preceding the study Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study Gastroenteritis in the last two weeks before inclusion</criteria>
	<gender>All</gender>
	<minimum_age>8 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Healthy infants</keyword>
	<keyword>Infant formula</keyword>
	<keyword>Prebiotics oligosaccharides</keyword>
	<keyword>Colonisation Resistance</keyword>
	<keyword>Gut Microbiota</keyword>
</DOC>